Genomate Health Acquires Oncompass Medicine

January 14, 2026

Genomate Health, a Cambridge-based precision medicine company, has acquired Hungarian personalized oncology firm Oncompass Medicine to expand its precision-oncology offerings and establish a stronger presence in Europe. The acquisition brings Oncompass's oncology decision‑support capabilities and customer relationships into Genomate's computational precision‑medicine platform.

Buyers
Genomate Health
Targets
Oncompass Medicine
Location
Budapest, Hungary
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.